Gujarat Exclusive >

Covishield

Covaxin, Covishield prices slashed; to cost Rs 225 per dose

New Delhi: A day before the Covid-19 booster dose is made available for adults at private vaccination centres, the prices of both Covaxin and Covishield were brought down. Both the Covid-19 vaccines will now cost Rs 225 per dose. Serum Institute of India manufactures Covishield in India while Covaxin is manufactured by Bharat Biotech. SII...

Fully ‘Covaxin-ated’, but want Covishield to travel abroad? Let’s wait for WHO decision, says SC

New Delhi: The delayed approval to Bharat Biotech’s Covid-19 vaccine Covaxin by the World Health Organization (WHO) has meant many an anxious moment for several individuals who have received it and are unable to travel to certain countries because of lack of approval to Covaxin. A petition in the Supreme Court had sought permission for...

India’s Covishield vaccination finally gets approval in UK; no quarantine for fully vaccinated travellers

New Delhi: Come Monday, Indian travellers to the United Kingdom (UK) will not be required to remain in isolation for 10 day, as had been mandated earlier, if they have received both the shots of Covid-19 vaccine Covishield. Announcing the development on Twitter, British High Commissioner to India Alex Ellis wrote, “No quarantine for India...

UK approves Covishield; yet to give recognition to India’s vaccine certificate

New Delhi: Close on the heels of New Delhi’s warning to the UK of reciprocal measures if it did not approve Covishield, the latter has included the AstraZeneca vaccine in its list of approved Covid-19 vaccines. However, there is no clarity on recognition to the vaccine certification in India, which still does not appear in...

Centre considering reducing the gap between two doses of Covishield

The Union government is considering reducing the interval between two doses of Covishield— the COVID-19 vaccine developed by AstraZeneca and the University of Oxford and locally manufactured by the Pune-based Serum Institute of India. As of now, the gap between two doses of Covishield is at least 84 days. Notably, the National Technical Advisory Group...

Serum Institute seeks permission for manufacturing Sputnik V, indemnity

Pune-based Serum Institute of India (SII) has sought permission from the Drug Controller General of India (DCGI) for manufacturing Sputnik V—the Russian vaccine against COVID-19. The application was made yesterday, according to media reports. Notably, SII, the biggest vaccine maker in the world, is already manufacturing Covishield—the COVID-19 vaccine developed by...

Govt panel recommends 12-16 weeks gap between two doses of Covishield

The National Immunization Technical Advisory Group has recommended that the gap between two doses of Covishield—the AstraZeneca vaccine against COVID-19—should be increased to 12-16 weeks. However, no change in vaccination schedule has been recommended for Bharat Biotech’s Covaxin which continues to remain 4-6 weeks. The government panel has also said that pregnant women...

Bharat Biotech reduces price of Covaxin for state governments

After the Serum Institute of India reduced the price of Covishield, the maker of Covaxin—Bharat Biotech—has followed suit. Bharat Biotech on Thursday reduced the price of its COVID-19 vaccine for state governments from Rs 600 to Rs 400. However, the price of Covaxin for private hospitals remains unchanged at Rs 1,200 per shot. In a...

After initial hiccups, CoWIN & Aarogya Setu back online

Within minutes of the opening of COVID-19 vaccine registrations for people in the age group of 18 and above, the Union government’s COVID-19 vaccination portal CoWIN crashed on Wednesday. Not just CoWIN, but glitches were also witnessed in the Aarogya Setu app. Social media platforms were full of complaints as the two apps failed to...

Gujarat govt orders 1.5 cr vaccines from Serum Institute, Bharat Biotech

The Gujarat government on Sunday announced that it has ordered 1.5 crore doses of COVID-19 vaccines from Bharat Biotech and Serum Institute to smoothly carry out the immunisation drive for people aged 18-45. The jabs will be administered to people belonging to this age group free of cost. The decision has been taken following a...

Adar Poonawalla urges Joe Biden to lift embargo on export of raw materials for COVID-19 vaccines

Pune-based Serum Institute of India’s CEO Adar Poonawalla has urged US President Joe Biden to lift the embargo on raw material exports that are required for the manufacturing of vaccines. Notably, the Serum Institute is manufacturing the jab ‘Covishield’ jointly developed by AstraZeneca and the University of Oxford. Notably, Covishield is one of the most...

Centre asks states to increase the gap between two doses of Covishield

The Union government has asked the state governments to increase the gap between two doses of Covishield—the jab developed against COVID-19 jointly by AstraZeneca and the University of Oxford and is being manufactured locally by Pune-based Serum Institute of India (SII). While the government had earlier recommended a gap of at least 28 days, it...